Moreover, achaete-scute homolog 1 (ASH1) also acts as a positive regulator of WNT/β-catenin pathway, transforming NSCLC into a SCLC phenotype with neuroendocrine features both in vitro and in vivo models [90]. This evidence concerns the gene ASCL1 and non-small cell lung carcinoma.